CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+40.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
-$37.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
444
New
Increased
Reduced
Closed

Top Buys

1
+$9.04M
2
+$8.47M
3
+$8.22M
4
MEOH icon
Methanex
MEOH
+$7.91M
5
CNX icon
CNX Resources
CNX
+$7.61M

Top Sells

1
+$15.2M
2
+$11.7M
3
+$11.4M
4
AMAT icon
Applied Materials
AMAT
+$9.19M
5
FANG icon
Diamondback Energy
FANG
+$8.2M

Sector Composition

1 Technology 25.63%
2 Financials 13.77%
3 Healthcare 11.98%
4 Industrials 9.97%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WOLF icon
401
Wolfspeed
WOLF
$940M
$253K 0.01%
11,137
-1,822
ZBH icon
402
Zimmer Biomet
ZBH
$19.4B
$218K 0.01%
2,008
-9,265
SRPT icon
403
Sarepta Therapeutics
SRPT
$1.66B
– –
-13,511
DENN
404
DELISTED
Denny's
DENN
– –
-605,496
BOOT icon
405
Boot Barn
BOOT
$5.68B
– –
-85,178
DAR icon
406
Darling Ingredients
DAR
$8.44B
– –
-5,023
DOC icon
407
Healthpeak Properties
DOC
$12.2B
– –
-34,807
EXC icon
408
Exelon
EXC
$50.1B
– –
-20,998
FLO icon
409
Flowers Foods
FLO
$1.95B
– –
-32,297
MDLZ icon
410
Mondelez International
MDLZ
$75.3B
– –
-31,728
ONON icon
411
On Holding
ONON
$14.5B
– –
-91,948
CABA icon
412
Cabaletta Bio
CABA
$313M
– –
-10,367
CLF icon
413
Cleveland-Cliffs
CLF
$6.32B
– –
-50,000
CYTK icon
414
Cytokinetics
CYTK
$7.42B
– –
-4,013
FRT icon
415
Federal Realty Investment Trust
FRT
$9.54B
– –
-6,379
GLOB icon
416
Globant
GLOB
$2.2B
– –
-7,688
IWM icon
417
iShares Russell 2000 ETF
IWM
$73.4B
– –
-961
LECO icon
418
Lincoln Electric
LECO
$15.4B
– –
-7,147
PVH icon
419
PVH
PVH
$3.05B
– –
-5,840
QDEL icon
420
QuidelOrtho
QDEL
$1.46B
– –
-9,157
SEE icon
421
Sealed Air
SEE
$6.18B
– –
-134,698
SLB icon
422
SLB Ltd
SLB
$72.6B
– –
-35,545
SMCI icon
423
Super Micro Computer
SMCI
$18.4B
– –
-39,580
SNV
424
DELISTED
Synovus
SNV
– –
-32,907
SYRE icon
425
Spyre Therapeutics
SYRE
$3.15B
– –
-6,835
14 15 16
17
18